MUC1 and neoplasm: Recently, it has been shown that tandem repeats of MUC1 are capable of activating nuclear factor Kappa‐light‐chain‐enhancer of activated B (NF‐κB), a transcription factor involved in pro‐inflammatory responses, induction of resistance to chemotherapy, tumor progression, invasion, and metastasis [37, 38, 39, 40].